Healthcare -
Biotechnology - NASDAQ - US
$ 279.01
0.667 %
$ 36 B
Market Cap
-106.09
P/E
ALNY - COST OF REVENUE
Cost of Revenue ALNY - Alnylam Pharmaceuticals, Inc.
310 M
LAST VALUE
48.83%
2 YEAR CAGR
180.05%
5 YEAR CAGR
0.00%
10 YEAR CAGR